首页 | 本学科首页   官方微博 | 高级检索  
     

磺脲受体1基因外显子16-3c/t多态性与格列齐特降血糖的关系
引用本文:张慧娟,刘晓民,匡洪宇,孙宏,邢厚恂. 磺脲受体1基因外显子16-3c/t多态性与格列齐特降血糖的关系[J]. 中国临床药理学杂志, 2007, 23(5): 369-371
作者姓名:张慧娟  刘晓民  匡洪宇  孙宏  邢厚恂
作者单位:1. 哈尔滨医科大学,第一临床医院内分泌科,哈尔滨,150001
2. 哈尔滨医科大学,公共卫生学院,哈尔滨,150001
3. 安徽省生物医学研究所,合肥,230022
基金项目:黑龙江省教育厅科学技术研究项目
摘    要:目的研究磺脲类药物受体1(SUR1)基因多态性与格列齐特降糖疗效的关系。方法用Taqman-PCR技术检测119例2型糖尿病患者SUR1基因型,分析基因型与血糖变化的关系。结果SUR1基因16外显子-3c/t位点的突变纯合子tt基因型患者,其基线空腹胰岛素水平高于野生纯合子cc基因型患者(P<0.05)。格列齐特治疗后,各基因型空腹血糖、餐后2h血糖、糖化血红蛋白、空腹胰岛素及胰岛素抵抗指数下降幅度均无显著性差异。结论16外显子-3c/t多态性与格列齐特降糖疗效无关。

关 键 词:2型糖尿病  基因多态性  格列齐特
文章编号:1001-6821(2007)05-0369-03
修稿时间:2006-06-21

Relationship between the polymorphism of sylfonylurea receptor 1 extron 16-3c/t and decreased the blood glucose of gliclazide
ZHANG Hui-juan,LIU Xiao-min,KUANG Hong-yu,SUN Hong,XING Hou-xun. Relationship between the polymorphism of sylfonylurea receptor 1 extron 16-3c/t and decreased the blood glucose of gliclazide[J]. The Chinese Journal of Clinical Pharmacology, 2007, 23(5): 369-371
Authors:ZHANG Hui-juan  LIU Xiao-min  KUANG Hong-yu  SUN Hong  XING Hou-xun
Affiliation:1. Department of Endocrinology, The First Clinical Hospital of Harbin Medical University, Harbin 150001, China ; 2. College of Public Health, Harbin Medical University, Harbin 150001, China ;3. Institute of Biomedicine, Anhui Medical University, Hefei 230032, China
Abstract:Objective To investigate the relationshipe between the polymorphism of sulfonylurea receptor 1 (SUR1) extron 16-3c/t and decreased the blood glucose of gliclazide. Methods SUR1 genotypes of 119 patients with type 2 diabetes were determined by Taqman-PCR. The association between the drug efficacy and genotypes was investigated.Results At baseline,the serum insulin of the group with tt genotype of SUR1 extron 16-3c/t was significantly higher than that of the group with cc genotype(P<0.05). After treatment extron 16-3c/t gene polymorphism was no associated with decrease of FPG, 2hPG,HbA1c,FINS and HOMA-IR (P>0.05). Conclusion Extron 16-3c/t gene polymorphism was no associated with the therapeutic efficacy of gliclazide,but related to insulin level.
Keywords:type 2 diabetes  gene polymorphism  gliclazide
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号